Livagen for Liver Health & Hepatic Tissue Support — Bioregulators
Khavinson bioregulator peptide for liver tissue regeneration and hepatic function optimization.
Overview
Livagen is a Khavinson bioregulator targeting liver and hepatic tissues for cellular regeneration and metabolic support. It works through DNA-level gene regulation in hepatocytes to restore liver function, support detoxification pathways, and optimize hepatic health. Livagen is particularly valuable for fatty liver disease, liver aging, metabolic dysfunction, and hepatic tissue repair after toxic exposure or alcohol use.
Indications
- Non-alcoholic fatty liver disease (NAFLD)
- Liver tissue repair and regeneration
- Hepatic function optimization in aging
- Post-alcohol or toxin exposure recovery
- Metabolic liver dysfunction support
- Detoxification pathway enhancement
- Hepatoprotection during medication use
Mechanism of Action
Fatty liver disease, age-related hepatic decline, or toxic liver injury
Dosing
| Compound | Dose | Frequency | Notes |
|---|---|---|---|
| Livagen | 20 mg | Once daily | Liver health maintenance and metabolic support |
| Livagen | 20 mg | Twice daily for first 2 months, then once daily | For NAFLD or hepatic dysfunction |
Safety & Contraindications
- Emerging evidence - Russian clinical studies
- No hepatotoxicity reported in clinical trials
- Generally safe for liver support
- Not a replacement for liver disease treatments
- Monitor liver enzymes (AST, ALT) during use
- Consult hepatologist with severe liver disease or cirrhosis